Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PF-08046052 by Pfizer for Non-Small Cell Lung Cancer: Likelihood of Approval
PF-08046052 is under clinical development by Pfizer and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
PF-08046052 by Pfizer for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
PF-08046052 is under clinical development by Pfizer and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...
PF-08046052 by Pfizer for Metastatic Colorectal Cancer: Likelihood of Approval
PF-08046052 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...
PF-08046052 by Pfizer for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
PF-08046052 is under clinical development by Pfizer and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC)....